Sienna Biopharmaceuticals, Inc.
SNNAQ
$0.00
$0.000.00%
OTC PK
| 09/30/2019 | 06/30/2019 | 03/31/2019 | 12/31/2018 | 09/30/2018 | |
|---|---|---|---|---|---|
| Net Income | 51.96% | 49.55% | 15.27% | -15.13% | 17.02% |
| Total Depreciation and Amortization | -2.70% | -5.13% | -2.50% | 2.56% | 0.00% |
| Total Amortization of Deferred Charges | 121.94% | 1.72% | 80.62% | -0.77% | -- |
| Total Other Non-Cash Items | -883.33% | -87.64% | 16.29% | 485.03% | 67.86% |
| Change in Net Operating Assets | -582.52% | 59.83% | -58.70% | -856.28% | -105.11% |
| Cash from Operations | -112.00% | 34.08% | 18.14% | 1.83% | -0.88% |
| Capital Expenditure | -- | 100.00% | 33.33% | 62.50% | -23.08% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | 33.33% | 62.50% | -23.08% |
| Total Debt Issued | -- | -- | -- | 129.55% | -100.15% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -100.00% | -97.89% | 8,083.97% | -94.80% | 533.58% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -188.89% | -- | -- |
| Cash from Financing | -4,524.78% | -97.89% | 7,212.63% | -94.13% | -83.73% |
| Foreign Exchange rate Adjustments | -66.67% | 130.00% | 92.70% | -- | 100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -375.30% | -192.12% | 155.95% | -41.58% | -173.36% |